Philips / BioTelemetry

Founded in Malvern in 1994 as CardioNet, later BioTelemetry, this operation leads in wearable cardiac-arrhythmia monitoring and clinical-trial cardiac services. Royal Philips acquired it for about $2.8 billion in 2021, and Malvern remains the business's primary U.S. site.